URGO Group is an international healthcare group specializing in advanced wound care, consumer health, and the treatment of complex conditions. Headquartered in Dijon, France, it is a family-owned industrial group with over 3,600 employees operating in roughly 70 countries. Core Business Divisions The group operates through two primary divisions: Urgo Medical: Dedicated to healing severe, chronic, and surgical wounds. It supports healthcare professionals with evidence-based treatments for conditions like diabetic foot ulcers, leg ulcers, and pressure sores. Urgo Consumer Healthcare: Focuses on everyday ailments for families, including first aid, face and mouth care (e.g., mouth ulcers), foot/hand care, and pain relief. Key Technologies and Products TLC (Technology Lipido-Colloid): A proprietary technology discovered in 2000 that creates a healing matrix for dressings. Filmogel®: Liquid dressings that protect and promote healing for ailments like cracks, cuts, and cold sores. UrgoStart: A dressing technology clinically proven to reduce healing time for diabetic foot ulcers. UrgoKTwo: A multicomponent compression system for treating venous and mixed leg ulcers. Healico: A digital mobile application for healthcare professionals to monitor and manage wound healing. Industrial Presence and Innovation URGO prioritizes "double innovation," meaning it develops the manufacturing facilities simultaneously with the products. Industrial Sites: The group maintains 10 production sites and 12 distribution centers globally. Genesis Project: A major disruptive research project aiming to produce artificial skin by the 2030s to treat severe wounds. R&D Commitment: The group invests heavily in research and clinical trials, such as those published in The Lancet, to prove the therapeutic effectiveness of its solutions. Company History and Expansion Founding: Created in 1958 by Jean Le Lous, a pharmacist in Dijon, as a French dressing business. Acquisitions: The group has expanded through strategic acquisitions, including Mercurochrome (1996), Marie-Rose (1997), and Juvamine (which introduced vitamins to supermarkets). Global Footprint: Expanded into Germany in the 1980s, Asia in the 1990s, and established a strong North American presence in 2018 through the acquisition of SteadMed. Mission and Culture The group's central mission is "Healing People," which focuses on reducing the suffering caused by wounds. It emphasizes a culture of partnership with healthcare providers and has been certified as a Great Place To Work in various regions.